Skip to content

The Efficacy and Safety of Rimazoram Tosilate in the Induction of General Anesthesia

The Efficacy and Safety of Rimazoram Tosilate in the Induction of General Anesthesia

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000031798
Enrollment
Unknown
Registered
2020-04-10
Start date
2020-04-13
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General Anesthesia

Interventions

Group 1:Rimazoram
Group 2:Propofol

Sponsors

The First People's Hospital of Lianyungang
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. 18 <= age <= 65, gender unlimited; 2. Patients undergoing elective surgery; 3. ASA score is grade I or II; 4. Patients with 18 kg / m2 < BMI < 30 kg / m2; 5. Patients who clearly understand and voluntarily participate in the study and are willing to sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients in emergency operation; patients in hypovolemia, shock or coma; 2. Patients who plan to use general intravenous anesthesia and need to combine other anesthesia methods, such as inhalation anesthesia and Epidural and subarachnoid anesthesia; 3. Patients with infectious heart diseases such as myocarditis or endocarditis or septicemia; 4. Uncontrolled hypertension, diabetes, heart failure, etc.; 5. Patients with abnormal liver function, AST and / or ALT >= 2.5 x ULN, TBIL >= 1.5 x ULN; 6. Patients with abnormal renal function, urea or urea nitrogen >= 1.5 x ULN, and creatinine > the upper limit of normal value; 7. Patients with mental system diseases (schizophrenia, mania, bipolar disorder, insanity etc.) or have a long history of taking psychoactive drugs, have cognitive dysfunction; 8. Pregnant or lactating women; 9. Patients who are allergic to benzodiazepines, opioids, propofol, muscle pines and other drugs, or who are allergic to or have contraindications to drug ingredients; 10. Other circumstances in which the researchers consider it inappropriate to participate in the trial.

Design outcomes

Primary

MeasureTime frame
Success rate of anesthesia induction;

Secondary

MeasureTime frame
Incidence of hypotension during induction of anesthesia;

Countries

China

Contacts

Public ContactXiaobao Zhang

Department of Anesthesiology, the First People's Hospital of Lianyungang

hotdog100@163.com+86 18961322507

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026